Amniotic tissue transplantation as a trial of treatment in some lysosomal storage diseases
Article
Received:
Accepted:
Abstract
This communication reports the clinical and biochemical results in six patients: four with mucopolysaccharidosis, one with GM1 gangliosidosis (Morquio B) and one with I-cell disease, who were treated by amniotic tissue transplantation. The sole evident clinical result was the diminishing of corneal clouding in three cases. A slight increase of beta-galactosidase activity in one patient's plasma was observed. The time of improvement was about 2 months after the transplantation and was transitory.
Keywords
Public Health Internal Medicine Clinical Result Metabolic Disease Storage Disease
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- Adinolfi, M., Akle, C. A., McColl, J., Fensom, A. M., Tansley, L., Connolly, P., Hsi, B. L., Faulk, W. P., Travers, P. and Bodmer, W. F. Expression of HLA antigens beta-2 microglobulin and enzyme by human amniotic epithelial cells.Nature, Lond. 295 (1982) 325–327Google Scholar
- Akle, C. A., Adinolfi, M., Welsh, K. J., Leibowitz,S. and McColl, J. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers.Lancet (1981) 1003–1005Google Scholar
- Dean, M. F., Muir, H., Benson, P. F. and Button, L. R. Enzyme replacement therapy by transplantation of HLA-compatible fibroblasts in Sanfillippo A syndrome.Pediatr. Res. 15 (1981) 959–963PubMedGoogle Scholar
- Dubois, G., Turpin, J. C. and Baumann, N. Arylsulphatase isoenzymes in meachomatic leucodystrophy detection of a new variant by electrophoresis improvement at quantitative assay.Biomedicine 23 (1975) 116–119PubMedGoogle Scholar
- Gibbs, D. A., Spellacy, E., Roberts, A. E. and Watts, R. W. E. The treatment of lysosomal storage diseases by fibroblast transplantation: some preliminary observations. InBirth Defects: Original Article Series, Vol. 16, Dimes Birth Defects Foundation, 1980, pp. 457–474Google Scholar
- Gibbs, D. A., Spellacy, E., Tompkins, R., Watts, R. W. E. and Mowbray, J. F. A clinical trial of fibroblast transplantation for the treatment of mucopolisaccharidosis.J. Inher. Metab. Dis. 6 (1983) 62–81PubMedGoogle Scholar
- Hobbs, J. R., Hugh, J. K., Barreti, A. J., Byron, N., Chambers, D., Henry, K., James, D. C. O., Lucas, C. F., Rogers, T. R., Benson, P. P., Tansley, L. R., Mossman, J., Young, F. P. and Patric, A. D. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone marrow transplantation.J. Inher. Metab. Dis. 5, Suppl. 1 (1982) 59–60PubMedGoogle Scholar
- Pennock, C. A. A modified screening test for glycosominoglycan excretion.J. Clin. Pathol. 22 (1969) 379Google Scholar
- Pennock, C. A. A review of simple laboratory methods used for study of glycosominoglycon excretion and diagnosis of mucopolysaccharidoses.J. Clin. Pathol. 29 (1976) 11–123PubMedGoogle Scholar
- Ratazzi, M. C.Enzyme Therapy in Lysosomal Storage Diseases: Current Approach in Human Genetics. Part B: Medical Aspects, Alan R. Liss, New York, 1982, pp. 573–587Google Scholar
- Sly, W. S. Prospects for enzyme replacement in storage diseases. InBirth Defects: Original Article Series, Vol. 16, Alan R. Liss, New York, 1981, pp. 201–213Google Scholar
- Sly, W. S., Natowicz, M. R., Gonzalez-Noniega, A. Grubb, J. H. and Fischer, H. D. The role of mannose-6-phosphate recognition marker and its receptor in the uptake and cellular transport of lysosomal storage diseases. Eds Callahan, J. W. and Lowcon, J. A., Raven Press, New York, 1981, pp. 131–146Google Scholar
Copyright information
© SSIEM and MTP Press Limited 1985